22:39:26 Europe / Stockholm

Bifogade filer

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Prenumeration

Kalender

2025-02-26 Bokslutskommuniké 2024
2024-11-27 Kvartalsrapport 2024-Q3
2024-08-28 Kvartalsrapport 2024-Q2
2024-05-22 Kvartalsrapport 2024-Q1
2024-05-02 Ordinarie utdelning ACOU 0.00 SEK
2024-04-30 Årsstämma 2024
2024-02-28 Bokslutskommuniké 2023
2023-11-07 Kvartalsrapport 2023-Q3
2023-08-24 Kvartalsrapport 2023-Q2
2023-05-31 Kvartalsrapport 2023-Q1
2023-04-26 Ordinarie utdelning ACOU 0.00 SEK
2023-04-25 Årsstämma 2023
2023-02-22 Bokslutskommuniké 2022
2022-11-23 Kvartalsrapport 2022-Q3
2022-08-24 Kvartalsrapport 2022-Q2
2022-05-18 Kvartalsrapport 2022-Q1
2022-04-28 Ordinarie utdelning ACOU 0.00 SEK
2022-04-27 Årsstämma 2022
2022-02-24 Bokslutskommuniké 2021
2021-12-21 Extra Bolagsstämma 2021
2021-11-24 Kvartalsrapport 2021-Q3
2021-08-25 Kvartalsrapport 2021-Q2
2021-05-26 Kvartalsrapport 2021-Q1
2021-04-28 Årsstämma 2021
2021-04-15 Ordinarie utdelning ACOU 0.00 SEK
2021-02-24 Bokslutskommuniké 2020
2020-11-25 Kvartalsrapport 2020-Q3
2020-08-26 Kvartalsrapport 2020-Q2
2020-06-10 Ordinarie utdelning ACOU 0.00 SEK
2020-06-09 Årsstämma 2020
2020-05-27 Kvartalsrapport 2020-Q1
2020-02-25 Bokslutskommuniké 2019
2019-11-20 Kvartalsrapport 2019-Q3
2019-08-21 Kvartalsrapport 2019-Q2
2019-06-18 Ordinarie utdelning ACOU 0.00 SEK
2019-06-17 Årsstämma 2019
2019-05-22 Kvartalsrapport 2019-Q1
2019-02-27 Bokslutskommuniké 2018
2018-11-22 Kvartalsrapport 2018-Q3
2018-08-23 Kvartalsrapport 2018-Q2
2018-06-14 Ordinarie utdelning ACOU 0.00 SEK
2018-06-13 Årsstämma 2018
2018-05-16 Kvartalsrapport 2018-Q1
2018-03-21 Extra Bolagsstämma 2018
2018-02-28 Bokslutskommuniké 2017
2017-11-24 Kvartalsrapport 2017-Q3
2017-08-25 Kvartalsrapport 2017-Q2
2017-06-19 Ordinarie utdelning ACOU 0.00 SEK
2017-06-16 Årsstämma 2017
2017-05-15 Kvartalsrapport 2017-Q1
2017-02-28 Bokslutskommuniké 2016
2016-11-25 Kvartalsrapport 2016-Q3

Beskrivning

LandSverige
ListaFirst North Stockholm
SektorHälsovård
IndustriBioteknik
AcouSort är verksamt inom medicinteknik. Idag har bolaget en utvecklad plattformsteknologi inriktad mot akustofores, som med hjälp utav ultraljud separerar och analyserar biologiska cellers sammansättningar. Tekniken används huvudsakligen vid analys av cancerfall och sepsis (blodförgiftning). En stor del av forskningen sker i samarbete med övriga aktörer inom Life-Science. Bolaget etablerades under 2010 och har sitt huvudkontor i Lund.
2023-11-14 08:42:08

AcouSort AB (publ) ("AcouSort" or the "Company") today publishes an information memorandum regarding the Company's forthcoming rights issue of so-called units ("Units") consisting of shares and warrants, resolved by the Board of Directors on 7 November 2023 (the "Rights Issue"). The information memorandum is available on the Company's website (www.acousort.com) and on Erik Penser Bank's website (www.penser.se). Upon full subscription in the Rights Issue the Company will initially receive approximately MSEK 24.8 before issuing costs.

THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, BELARUS, HONG KONG, JAPAN, CANADA, NEW ZEALAND, RUSSIA, SWITZERLAND, UNITED KINGDOM, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, OR ANY OTHER JURISDICTION WHERE SUCH ACTION IS WHOLLY OR PARTIALLY SUBJECT TO LEGAL RESTRICTIONS. SEE ALSO THE "IMPORTANT INFORMATION" SECTION BELOW.

AcouSort today publishes an information memorandum concerning the Company's forthcoming Rights Issue. The information memorandum is available on the Company's website (www.acousort.com) and Erik Penser Bank's website (www.penser.se).

Terms for the Rights Issue
  • Each existing share held in the Company on the record date of 14 November 2023, entitles the holder to one (1) unit right. Twenty-four (24) unit rights entitle the holder to subscribe for one (1) Unit. One (1) Unit consists of three (3) shares and one (1) warrant of series TO 2 (the "Warrants").
  • In total, no more than 551,998 Units will be issued, meaning that up to 1,655,994 new shares and 551,998 warrants will be issued.
  • The subscription price for one (1) Unit is SEK 45.00, which corresponds to SEK 15.00 per new share. The Warrants are issued free of charge.
  • The dilution effect amounts to approximately 11.1 percent if the Rights Issue of Units is fully subscribed and to a total of approximately 14.3 percent if a subsequent full subscription of shares is made with the support of the Warrants. Shareholders have the opportunity to economically compensate for the dilution by selling their unit rights by 27 November 2023, at the latest.
  • The subscription period runs from and including 16 November 2023 up to and including 30 November 2023, with the right for AcouSort's Board of Directors to extend the subscription period and the time for payment. Trading in unit rights will take place on Nasdaq First North Growth Market during the period from and including 16 November 2023 up to and including 27 November 2023, and trading in BTU (paid subscribed units) will occur during the period from and including 16 November 2023 up to registration of the Rights Issue at the Swedish Companies Registration Office, which is expected to take place around week 49, 2023.
  • For complete terms and instructions for the Rights Issue, please refer to the information memorandum.

Preliminary time plan for the Rights Issue

+-------------------------------------------+----------------------------------+
|November 14, 2023 |Record date for participation in |
| |the Rights Issue |
+-------------------------------------------+----------------------------------+
|November 16 - November 27, 2023 |Trading in unit rights on Nasdaq |
| |First North Growth Market |
+-------------------------------------------+----------------------------------+
|November 16 - November 30, 2023 |Subscription period for the Rights|
| |Issue |
+-------------------------------------------+----------------------------------+
|November 16 - registration of the Rights |Trading in BTU (paid subscribed |
|Issue at the Swedish Companies Registration|units) |
|Office | |
+-------------------------------------------+----------------------------------+
|December 4, 2023 |Estimated date for the publication|
| |of the outcome of the Rights Issue|
+-------------------------------------------+----------------------------------+
|March 10 - March 24, 2025 |Subscription period for exercise |
| |of Warrants |
+-------------------------------------------+----------------------------------+

Advisors

Erik Penser Bank AB is the financial advisor and issuing agent and Fredersen Advokatbyrå AB is legal advisor to AcouSort in connection with the Rights Issue.